Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Becton Dickinson Yönetim

Yönetim kriter kontrolleri 3/4

Becton Dickinson's CEO'su Tom Polen, Apr2017 tarihinde atandı, in görev süresi 7.5 yıldır. in toplam yıllık tazminatı $ 17.31M olup, şirket hissesi ve opsiyonları dahil olmak üzere 7.6% maaş ve 92.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.02% ine doğrudan sahiptir ve bu hisseler $ 14.20M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.8 yıl ve 7 yıldır.

Anahtar bilgiler

Tom Polen

İcra Kurulu Başkanı

US$17.3m

Toplam tazminat

CEO maaş yüzdesi	7.6%
CEO görev süresi	7.5yrs
CEO sahipliği	0.02%
Yönetim ortalama görev süresi	2.8yrs
Yönetim Kurulu ortalama görev süresi	7yrs

Son yönetim güncellemeleri

Recent updates

Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

Jul 16

An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

Jun 27

Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

May 24

Becton, Dickinson and Company: Stagnating All Along

May 16

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Mar 23

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Feb 29

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Feb 08

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Feb 03

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Feb 01

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Jan 22

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 30

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Nov 13

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Nov 12

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Nov 06

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Oct 05

Becton, Dickinson Stock Is A Hold, Here's Why

Oct 04

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

Aug 30

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Aug 13

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Jul 28

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching

Jun 22

Becton, Dickinson and Company: Still Not Very Healthy

Jun 20

Becton, Dickinson: Business Should Beat H2 2023 Expectations

Jun 08

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Apr 22

Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?

Mar 20

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Mar 05

Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use

Feb 21

Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test

Feb 08

Becton, Dickinson Q1 2023 Earnings Preview

Feb 01

Becton, Dickinson declares $0.91 dividend

Jan 24

CEO Tazminat Analizi

Tom Polen'un ücretlendirmesi Becton Dickinson'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	US$1b
Mar 31 2024	n/a	n/a	US$1b
Dec 31 2023	n/a	n/a	US$1b
Sep 30 2023	US$17m	US$1m	US$1b
Jun 30 2023	n/a	n/a	US$2b
Mar 31 2023	n/a	n/a	US$2b
Dec 31 2022	n/a	n/a	US$1b
Sep 30 2022	US$17m	US$1m	US$2b
Jun 30 2022	n/a	n/a	US$1b
Mar 31 2022	n/a	n/a	US$1b
Dec 31 2021	n/a	n/a	US$1b
Sep 30 2021	US$14m	US$1m	US$2b
Jun 30 2021	n/a	n/a	US$1b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	n/a	n/a	US$2b
Sep 30 2020	US$12m	US$952k	US$245m
Jun 30 2020	n/a	n/a	US$786m
Mar 31 2020	n/a	n/a	US$923m
Dec 31 2019	n/a	n/a	US$760m
Sep 30 2019	US$6m	US$900k	US$1b
Jun 30 2019	n/a	n/a	US$784m
Mar 31 2019	n/a	n/a	US$926m
Dec 31 2018	n/a	n/a	US$894m
Sep 30 2018	US$6m	US$850k	US$159m

Tazminat ve Piyasa: Tom 'nin toplam tazminatı ($USD 17.31M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 13.04M ).

Tazminat ve Kazançlar: Tom 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Tom Polen (51 yo)

7.5yrs

Görev süresi

US$17,309,938

Tazminat

Mr. Thomas E. Polen, Jr., also known as Tom, serves as Chief Executive Officer and Director at Becton, Dickinson and Company since January 28, 2020. Mr. Polen has been Director at Walgreens Boots Alliance,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Thomas Polen	President	7.5yrs	US$17.31m	0.020% $ 14.0m
Christopher DelOrefice	Executive VP & CFO	3.1yrs	US$5.21m	0.0044% $ 3.1m
Shana Neal	Executive VP & Chief People Officer	2.5yrs	US$5.89m	0.0057% $ 3.9m
Michael Garrison	Executive VP & President of Medical segment	2.1yrs	US$3.65m	0.0019% $ 1.3m
Thomas Spoerel	Senior VP	5yrs	Veri yok	0.00071% $ 488.9k
Elizabeth McCombs	Executive VP & Chief Technology Officer	3.5yrs	Veri yok	Veri yok
Joseph Smith	Senior VP	2.9yrs	Veri yok	Veri yok
Denise Fleming	Executive VP of Technology & Global Services and Chief Information Officer	2.8yrs	Veri yok	Veri yok
Greg Rodetis	Head of Investor Relations	less than a year	Veri yok	Veri yok
Michelle Quinn	Executive VP & General Counsel	1.7yrs	Veri yok	0.0017% $ 1.2m
Claudia Curtis	Senior VP	no data	Veri yok	Veri yok
Carla Burigatto	Senior VP & Chief Communications Officer	no data	Veri yok	Veri yok

2.8yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim: BDX 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Thomas Polen	President	4.8yrs	US$17.31m	0.020% $ 14.0m
Joseph Smith	Senior VP	2.9yrs	Veri yok	Veri yok
John DeFord	Co-Chair of Scientific Advisory Board	3.4yrs	Veri yok	Veri yok
Robert Eckert	Independent Director	8.1yrs	US$362.77k	0.0028% $ 1.9m
Timothy Ring	Independent Director	7.8yrs	US$332.78k	0.020% $ 14.1m
Jeffrey Henderson	Independent Director	6.2yrs	US$357.78k	0.0019% $ 1.3m
Christopher Ian Jones	Independent Director	14.3yrs	US$362.78k	0.0074% $ 5.1m
Bertram Scott	Lead Independent Director	22.1yrs	US$372.78k	0.012% $ 8.4m
Catherine Burzik	Independent Director	11.8yrs	US$357.78k	0.0046% $ 3.2m
William Brown	Independent Director	2.7yrs	US$332.78k	0.00087% $ 599.0k
Claire Fraser-Liggett	Member of Scientific Advisory Board & Independent Director	17.9yrs	US$340.15k	0.0078% $ 5.4m
Carrie Byington	Independent Director	3yrs	US$337.78k	0.00099% $ 681.7k

7.0yrs

Ortalama Görev Süresi

62yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: BDX 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 7 yıldır).

Becton Dickinson Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

BD Names Michael Feld as President of Life Sciences Segment, Effective August 20, 2024

Dave Hickey Retires as Executive Vice President and President of the Life Sciences Segment for BD, Effective from July 1, 2024

Becton, Dickinson and Company, Annual General Meeting, Jan 23, 2024

Becton, Dickinson and Company Announces Executive Changes

BD Names Greg Rodetis as Senior Vice President of Investor Relations

Becton, Dickinson and Company Elects Joanne Waldstreicher to the Board and as Member of the Corporate Governance and Nominating Committee and the Quality and Regulatory Committee of the Board

Recent updates

Becton, Dickinson and Company Reaches Multi-Year Settlement in Hernia Mesh Lawsuits

Here's Why Becton Dickinson (NYSE:BDX) Can Manage Its Debt Responsibly

Becton, Dickinson and Company: Future Benefit From GLP-1 Drug Delivery

Becton, Dickinson and Company (NYSE:BDX) completed the acquisition of Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW).

Upcoming dividend of US$0.95 per share

BD Names Michael Feld as President of Life Sciences Segment, Effective August 20, 2024

Becton, Dickinson And Company: Somewhat Undervalued, A Very Moderate Buy

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Becton, Dickinson and Company Updates Earnings Guidance for the Year 2024

Second quarter dividend of US$0.95 announced

Becton, Dickinson and Company Declares Quarterly Dividend, Payable on September 30, 2024

Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price

Becton, Dickinson and Company to Report Q3, 2024 Results on Aug 01, 2024

An Intrinsic Calculation For Becton, Dickinson and Company (NYSE:BDX) Suggests It's 36% Undervalued

BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool

Becton, Dickinson and Company (NYSE:BDX) entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.

Upcoming dividend of US$0.95 per share

Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?

Becton, Dickinson and Company: Stagnating All Along

Becton, Dickinson and Company Revises Earnings Guidance for the Fiscal Year 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations

Becton, Dickinson and Company Declares Quarterly Dividend, Payable on June 28, 2024

Becton, Dickinson and Company (NYSE:BDX) acquired FlowJo LLC.

Becton, Dickinson and Company to Report Q2, 2024 Results on May 02, 2024

Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson and Company Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease

Dave Hickey Retires as Executive Vice President and President of the Life Sciences Segment for BD, Effective from July 1, 2024

Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)

Upcoming dividend of US$0.95 per share

Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings

Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

First quarter 2024 earnings: EPS exceeds analyst expectations

Becton, Dickinson and Company Raises Earnings Guidance for the Fiscal Year of 2024

These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well

Fourth quarter dividend of US$0.95 announced

Becton, Dickinson and Company Declares Quarterly Dividend, Payable on March 29, 2024

Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play

Becton, Dickinson and Company to Report Q1, 2024 Results on Feb 01, 2024

Becton, Dickinson and Company, Annual General Meeting, Jan 23, 2024

BD Receives FDA 510(K) Clearance for Potentially Transformative Fingertip Blood Collection Device

Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year

BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency

Upcoming dividend of US$0.95 per share at 1.6% yield

Becton, Dickinson and Company Announces Executive Changes

Full year 2023 earnings: EPS misses analyst expectations

Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24

Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's

Becton, Dickinson and Company Increases Quarterly Dividend, Payable on December 29, 2023

Consensus EPS estimates fall by 20%

Becton, Dickinson and Company Provides Earnings Guidance for the Fiscal Year 2024

Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price

Becton, Dickinson and Company Announces Launch of Next-Generation Needle-Free Blood Draw Technology

BD Names Greg Rodetis as Senior Vice President of Investor Relations

Becton, Dickinson and Company to Report Q4, 2023 Results on Nov 09, 2023

Now 21% undervalued

With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case

Becton, Dickinson Stock Is A Hold, Here's Why

Now 20% undervalued

Upcoming dividend of US$0.91 per share at 1.3% yield

Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers

We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt

Becton, Dickinson and Company Raises Earnings Guidance for the Fiscal Year 2023

New minor risk - Earnings quality

Third quarter 2023 earnings: EPS misses analyst expectations

Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson and Company Elects Joanne Waldstreicher to the Board and as Member of the Corporate Governance and Nominating Committee and the Quality and Regulatory Committee of the Board

Becton, Dickinson and Company Receives FDA 510(k) Clearance for Updated BD Alaris™? Infusion System

Becton, Dickinson and Company to Report Q3, 2023 Results on Aug 03, 2023

Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching